AI Article Synopsis

  • Fufang Zaoren capsules show some effectiveness in treating insomnia, but the design of current clinical studies needs improvement.
  • At recommended doses, users may experience adverse reactions like chills, fever, and dizziness, while higher doses can lead to serious symptoms like extrapyramidal symptoms.
  • The capsules contain L-tetrahydropalmatine, which is linked to liver damage in pregnant women, prompting a need for better risk management in their clinical use.

Article Abstract

By comprehensive review and analysis of post-marketing clinical research on the efficacy and safety,we concluded that Fufang Zaoren capsule has certain therapeutic effects for insomnia, although current clinical research design needs improving. The post-marketing clinical studies also showed that it causes several adverse reactions at the recommended doses, such as chills, fever, dizziness, nausea, shortness of breath, chest tightness and palpitations, whereas high doses of Fufang Zaoren capsule can cause delayed extrapyramidal symptoms. Health Canada government website also prompted the L-tetrahydropalmatine in Fufang Zaoren capsule caused liver damage in pregnant women. The authors summarized the risk points, factors and risk control in the clinical use of Fufang Zaoren capsule and also present their perspective on the research status, existing problems and corresponding countermeasures in the post-marketing clinical re-evaluation of traditional Chinese medicine.

Download full-text PDF

Source

Publication Analysis

Top Keywords

fufang zaoren
20
zaoren capsule
16
post-marketing clinical
12
traditional chinese
8
fufang
5
zaoren
5
clinical
5
[post-marketing clinical
4
clinical study
4
study traditional
4

Similar Publications

Article Synopsis
  • Fufang Zaoren capsules show some effectiveness in treating insomnia, but the design of current clinical studies needs improvement.
  • At recommended doses, users may experience adverse reactions like chills, fever, and dizziness, while higher doses can lead to serious symptoms like extrapyramidal symptoms.
  • The capsules contain L-tetrahydropalmatine, which is linked to liver damage in pregnant women, prompting a need for better risk management in their clinical use.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!